CEACAM5 and neoplasm: Next, we evaluated the ability of two distinct tumor-associated antigens (i.e., CEA and MSLN) to redirect dCAR-T cells to cognate tumor cell AsPC-1, using antigen-negative PANC-1 cell line as a control.